You have free access to this content

Hepatology

Cover image for Hepatology

February 2013

Volume 57, Issue 2

Pages 429–856

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads (pages 441–450)

      Tai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, Tung-Hung Su, Chia-Chi Wang, Chi-Ling Chen, Cheng-An Hsu, Stephanie Fang-Tzu Kuo, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen and Jia-Horng Kao

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.26041

    2. You have free access to this content
      Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost-effectiveness (pages 451–460)

      Hamish A. Innes, Sharon J. Hutchinson, Stephen Barclay, Elaine Cadzow, John F. Dillon, Andrew Fraser, David J. Goldberg, Peter R. Mills, Scott A. McDonald, Judith Morris, Adrian Stanley, Peter Hayes and on behalf of the Hepatitis C Clinical Database Monitoring Committee

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26051

    3. You have free access to this content
      IFITM1 is a tight junction protein that inhibits hepatitis C virus entry (pages 461–469)

      Courtney Wilkins, Jessica Woodward, Daryl T.-Y. Lau, Amy Barnes, Michael Joyce, Nicola McFarlane, Jane A. McKeating, D. Lorne Tyrrell and Michael Gale Jr.

      Version of Record online: 12 DEC 2012 | DOI: 10.1002/hep.26066

    4. You have free access to this content
      Hepatitis B virus polymerase impairs interferon-α–induced STA T activation through inhibition of importin-α5 and protein kinase C-δ (pages 470–482)

      Jieliang Chen, Min Wu, Xiaonan Zhang, Wen Zhang, Zhanqing Zhang, Lixiang Chen, Jing He, Ye Zheng, Cuncun Chen, Fan Wang, Yunwen Hu, Xiaohui Zhou, Cong Wang, Yang Xu, Mengji Lu and Zhenghong Yuan

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26064

    5. You have free access to this content
      Investigation of residual hepatitis C virus in presumed recovered subjects (pages 483–491)

      Kei Fujiwara, Robert D. Allison, Richard Y. Wang, Patricia Bare, Kentaro Matsuura, Cathy Schechterly, Krishna Murthy, Francesco M. Marincola and Harvey J. Alter

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.25921

    6. You have free access to this content
      The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination (pages 492–504)

      Muhammad N. Zahid, Marine Turek, Fei Xiao, Viet Loan Dao Thi, Maryse Guérin, Isabel Fofana, Philippe Bachellier, John Thompson, Leen Delang, Johan Neyts, Dorothea Bankwitz, Thomas Pietschmann, Marlène Dreux, François-Loïc Cosset, Fritz Grunert, Thomas F. Baumert and Mirjam B. Zeisel

      Version of Record online: 28 DEC 2012 | DOI: 10.1002/hep.26097

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease (pages 505–514)

      Mercedes Vazquez-Chantada, Aintzane Gonzalez-Lahera, Ibon Martinez-Arranz, Carmelo Garcia-Monzon, Manuela M. Regueiro, Juan L. Garcia-Rodriguez, Karin A. Schlangen, Iñaki Mendibil, Naiara Rodriguez-Ezpeleta, Juan J. Lozano, Karina Banasik, Johanne M. Justesen, Torben Joergensen, Daniel R. Witte, Torsten Lauritzen, Torben Hansen, Oluf Pedersen, Nicolas Veyrie, Karine Clement, Joan Tordjman, Albert Tran, Yannik Le Marchand-Brustel, Xabier Buque, Patricia Aspichueta, Jose J. Echevarria-Uraga, Antonio Martin-Duce, Joan Caballeria, Philippe Gual, Azucena Castro, Jose M. Mato, Maria L. Martinez-Chantar and Ana M. Aransay

      Version of Record online: 27 NOV 2012 | DOI: 10.1002/hep.26052

    2. You have free access to this content
    3. You have free access to this content
      Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes (pages 525–532)

      Joo-Won Park, Woo-Jae Park, Yael Kuperman, Sigalit Boura-Halfon, Yael Pewzner-Jung and Anthony H. Futerman

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.26015

    4. You have free access to this content
      MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia (pages 533–542)

      Kasey C. Vickers, Bassem M. Shoucri, Michael G. Levin, Han Wu, Daniel S. Pearson, David Osei-Hwedieh, Francis S. Collins, Alan T. Remaley and Praveen Sethupathy

      Version of Record online: 6 JUL 2012 | DOI: 10.1002/hep.25846

    5. You have free access to this content
      A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice (pages 543–554)

      Frank K. Huynh, Ursula H. Neumann, Ying Wang, Brian Rodrigues, Timothy J. Kieffer and Scott D. Covey

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.26043

    6. You have free access to this content
      Wilson's disease: Changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease (pages 555–565)

      Valentina Medici, Noreene M. Shibata, Kusum K. Kharbanda, Janine M. LaSalle, Rima Woods, Sarah Liu, Jesse A. Engelberg, Sridevi Devaraj, Natalie J. Török, Joy X. Jiang, Peter J. Havel, Bo Lönnerdal, Kyoungmi Kim and Charles H. Halsted

      Version of Record online: 10 JAN 2013 | DOI: 10.1002/hep.26047

    7. You have free access to this content
      Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model (pages 566–576)

      Marcela Aparicio-Vergara, Pascal P.H. Hommelberg, Marijke Schreurs, Nanda Gruben, Rinke Stienstra, Ronit Shiri-Sverdlov, Niels J. Kloosterhuis, Alain de Bruin, Bart van de Sluis, Debby P.Y. Koonen and Marten H. Hofker

      Version of Record online: 10 JAN 2013 | DOI: 10.1002/hep.26046

    8. You have free access to this content
    9. You have free access to this content
      Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease (pages 590–600)

      Leon A. Adams, Scott W. White, Julie A. Marsh, Stephen J. Lye, Kristin L. Connor, Richard Maganga, Oyekoya T. Ayonrinde, John K. Olynyk, Trevor A. Mori, Lawrence J. Beilin, Lyle J. Palmer, Jeffrey M. Hamdorf and Craig E. Pennell

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26184

    10. You have free access to this content
      Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH (pages 601–609)

      Lixin Zhu, Susan S. Baker, Chelsea Gill, Wensheng Liu, Razan Alkhouri, Robert D. Baker and Steven R. Gill

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26093

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma (pages 610–624)

      Limin Xia, Wenjie Huang, Dean Tian, Hongwu Zhu, Xingshun Qi, Zheng Chen, Yongguo Zhang, Hao Hu, Daiming Fan, Yongzhan Nie and Kaichun Wu

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26029

    2. You have free access to this content
      Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib (pages 625–636)

      Kristin Wahl, Martin Siegemund, Frank Lehner, Florian Vondran, Andreas Nüssler, Florian Länger, Till Krech, Roland Kontermann, Michael P. Manns, Klaus Schulze-Osthoff, Klaus Pfizenmaier and Heike Bantel

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26082

    3. You have free access to this content
      Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b (pages 637–647)

      Dorothy Ngo-Yin Fan, Felice Ho-Ching Tsang, Aegean Hoi-Kam Tam, Sandy Leung-Kuen Au, Carmen Chak-Lui Wong, Lai Wei, Joyce Man-Fong Lee, Xianghuo He, Irene Oi-Lin Ng and Chun-Ming Wong

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.26083

    4. You have free access to this content
      Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk (pages 648–655)

      Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, W. Ray Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau and Lewis R. Roberts

      Version of Record online: 12 DEC 2012 | DOI: 10.1002/hep.26092

    5. You have free access to this content
      Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis (pages 656–666)

      Wei-Dong Chen, Donna Yu, Barry M. Forman, Wendong Huang and Yan-Dong Wang

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26019

    6. You have free access to this content
    7. You have free access to this content
      Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3 (pages 678–688)

      Jiajie Hou, Juan Xu, Runqiu Jiang, Youjing Wang, Chen Chen, Lei Deng, Xingxu Huang, Xuehao Wang and Beicheng Sun

      Version of Record online: 30 OCT 2012 | DOI: 10.1002/hep.25980

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Immunoproteomic Analysis of Potentially Severe Non-Graft-Versus-Host Disease Hepatitis After Allogenic Bone Marrow Transplantation (pages 689–699)

      Elvire Beleoken, Rodolphe Sobesky, Jean-Pierre Le Caer, François Le Naour, Mylène Sebagh, Nicolas Moniaux, Bruno Roche, Mohammad Zahid Mustafa, Catherine Guettier, Catherine Johanet, Didier Samuel, Jean-Henri Bouhris, Jean-Charles Duclos-Vallee and Eric Ballot

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26024

    2. You have free access to this content
      Keratin 19 demonstration of canal of hering loss in primary biliary cirrhosis: “Minimal Change PBC”? (pages 700–707)

      Fahad M. Khan, Arathi Rajendra Komarla, Paulo G. Mendoza, Henry C. Bodenheimer Jr and Neil D. Theise

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26020

    3. You have free access to this content
      Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis (pages 708–715)

      Amy Dhirapong, Guo-Xiang Yang, Steven Nadler, Weici Zhang, Koichi Tsuneyama, Patrick Leung, Stuart Knechtle, Aftab A. Ansari, Ross L. Coppel, Fu-Tong Liu, Xiao-Song He and M. Eric Gershwin

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26067

    4. You have full text access to this OnlineOpen article
      Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype (pages 716–726)

      Shadi Abu-Hayyeh, Georgia Papacleovoulou, Anita Lövgren-Sandblom, Mehreen Tahir, Olayiwola Oduwole, Nurul Akmal Jamaludin, Sabiha Ravat, Vanya Nikolova, Jenny Chambers, Clare Selden, Myrddin Rees, Hanns-Ulrich Marschall, Malcolm G. Parker and Catherine Williamson

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26055

    5. You have free access to this content
      Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury (pages 727–739)

      Manal M. Monshi, Lee Faulkner, Andrew Gibson, Rosalind E. Jenkins, John Farrell, Caroline J. Earnshaw, Ana Alfirevic, Karin Cederbrant, Ann K. Daly, Neil French, Munir Pirmohamed, B. Kevin Park and Dean J. Naisbitt

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26077

    6. You have free access to this content
      Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor (pages 740–752)

      Lieke M. van der Velden, Misha V. Golynskiy, Ingrid T. G. W. Bijsmans, Saskia W. C. van Mil, Leo W. J. Klomp, Maarten Merkx and Stan F.J. van de Graaf

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26012

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Association of AKI With mortality and complications in hospitalized patients with cirrhosis (pages 753–762)

      Justin M. Belcher, Guadalupe Garcia-Tsao, Arun J. Sanyal, Harjit Bhogal, Joseph K. Lim, Naheed Ansari, Steven G. Coca, Chirag R. Parikh and for the TRIBE-AKI Consortium

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.25735

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Beta-catenin–NF-κB interactions in murine hepatocytes: A complex to die for (pages 763–774)

      Kari Nejak-Bowen, Alexander Kikuchi and Satdarshan P.S. Monga

      Version of Record online: 10 JAN 2013 | DOI: 10.1002/hep.26042

    2. You have free access to this content
      Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts (pages 775–784)

      Rachael A. Turner, Eliane Wauthier, Oswaldo Lozoya, Randall McClelland, James E. Bowsher, Claire Barbier, Glenn Prestwich, Edward Hsu, David A. Gerber and Lola M. Reid

      Version of Record online: 10 JAN 2013 | DOI: 10.1002/hep.26065

    3. You have free access to this content
      Reduced hepatic stellate cell expression of kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury (pages 786–796)

      Zahra Ghiassi-Nejad, Virginia Hernandez-Gea, Christopher Woodrell, Ursula E. Lang, Katja Dumic, Allison Kwong and Scott L. Friedman

      Version of Record online: 6 DEC 2012 | DOI: 10.1002/hep.26056

    4. You have free access to this content
      Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes (pages 797–805)

      Hacer Sahin, Erawan Borkham-Kamphorst, Nicole T. do O, Marie-Luise Berres, Michaela Kaldenbach, Petra Schmitz, Ralf Weiskirchen, Christian Liedtke, Konrad L. Streetz, Kathrin Maedler, Christian Trautwein and Hermann E. Wasmuth

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26069

    5. You have free access to this content
      Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice (pages 806–816)

      Masanobu Tsuda, Weici Zhang, Guo-Xiang Yang, Koichi Tsuneyama, Yugo Ando, Kazuhito Kawata, Ogyi Park, Patrick S.C. Leung, Ross L. Coppel, Aftab A. Ansari, William M. Ridgway, Bin Gao, Zhe-Xiong Lian, Richard Flavell, Xiao-Song He and M.Eric Gershwin

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.25829

    6. You have full text access to this OnlineOpen article
      Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response (pages 817–828)

      Anna Moles, Ana M. Sanchez, Paul S. Banks, Lindsay B. Murphy, Saimir Luli, Lee Borthwick, Andrew Fisher, Steven O'Reilly, Jacob M. van Laar, Steven A. White, Neil D. Perkins, Alastair D. Burt, Derek A. Mann and Fiona Oakley

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26068

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis (pages 829–839)

      Lei Zhao, Su Yin Lim, Alex N. Gordon-Weeks, Thomas T. Tapmeier, Jae Hong Im, Yunhong Cao, John Beech, Danny Allen, Sean Smart and Ruth J. Muschel

      Version of Record online: 8 JAN 2013 | DOI: 10.1002/hep.26094

  9. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
  10. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
  11. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have free access to this content
      Flipping the Switch (pages 851–852)

      Rishi Agarwal, Joseph Buell and Nathan J. Shores

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.26193

      Corrected by:

      Correction: Flipping the switch

      Vol. 58, Issue 3, 1193, Version of Record online: 31 JUL 2013

  12. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    1. You have full text access to this OnlineOpen article
      Practice guidelines on NAFLD (page 853)

      Melissa Palmer

      Version of Record online: 4 JAN 2013 | DOI: 10.1002/hep.25998

    2. You have free access to this content
      Reply (pages 853–854)

      Naga Chalasani

      Version of Record online: 7 JAN 2013 | DOI: 10.1002/hep.26199

    3. You have full text access to this OnlineOpen article
      Heterogeneous claudin-1 expression in human liver (pages 854–855)

      Helen J. Harris, Garrick K. Wilson, Stefan G. Hübscher and Jane A. McKeating

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.25910

    4. You have free access to this content
      Reply: (page 855)

      Laura Mensa, Sofia Perez-del-Pulgar and Xavier Forns

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.25909

    5. You have free access to this content
      Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals (pages 855–856)

      Kathleen O'sullivan, John Levis, Kevin Hegarty, Orla Crosbie, Elizabeth Kenny-Walsh and Liam J. Fanning

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.25942

    6. You have free access to this content
      Reply: (page 856)

      Patrick R. Harrington, Lisa K. Naeger and Wen Zeng

      Version of Record online: 5 FEB 2013 | DOI: 10.1002/hep.25948

SEARCH

SEARCH BY CITATION